Hepatology Highlights

 
 
  • Hepatitis C: 5 Things to Know Despite HCV being a curable disease with short-duration, well-tolerated finite therapy, it cannot be dismissed yet. Here are five issues that still need attention.
  • Drug-Induced Liver Injury: 5 Things to Know A guide to drug-induced liver injury--difficult to predict and challenging to recognize, and often with a bewildering range of presentations.
  • PBC: The Latest Data on an Evolving Disorder Dr Rowen Zetterman on diagnosing, managing, and treating this recently renamed autoimmune disorder.
  • Sarcopenia in Liver Disease Patients with end-stage liver disease are at an increased risk of developing sarcopenia; however, early recognition and management prior to liver transplantation may improve post-transplant outcomes.
  • Treating Alcoholic Liver Diseases Dr Rowen Zetterman on how promoting early alcohol abstinence, looking for comorbidities, and implementing other techniques may keep a bad situation from getting worse.
  • NAFLD Is a Growing Problem Recent guidance from the American Association for the Study of Liver Diseases for the evaluation and management of patients with nonalcoholic fatty liver disease is profiled.
  • Combating Frailty's Fatal Impact in Liver Disease Dr Rowen Zetterman on the various ways in which frailty imperils outcomes in liver disease, and the most useful strategies for addressing them.
  • Coffee May Increase Life Expectancy in Liver Disease Steep benefits! The latest data link coffee consumption to decreased morbidity and mortality in liver disease.
  • Updated Advice on Managing Liver Disease During Pregnancy Dr Rowen Zetterman reviews the new American College of Gastroenterology guidelines on caring for pregnant patients with diseases ranging from liver masses to viral infections.
  • Managing Upper GI Bleeding Due to Portal Hypertension Dr Rowan Zetterman examines new practice guidance for the diagnosis and management of patients with cirrhosis and portal hypertension.
  • Liver Disease and the Gut Microbiome What role does the gut microbiome play in the development of liver injury and end-stage liver disease?
  • Is It Covert or Overt Hepatic Encephalopathy? Hepatic encephalopathy manifests as a wide spectrum of abnormalities, ranging from subclinical alterations to coma. Careful testing, diagnosis, and treatment are required.
  • Portal Vein Thrombosis: Early Recognition, Improved Outcomes Although rare in the general populace, portal vein thrombosis can present secondary to various liver diseases and infections.
  • Deciding on the Best Treatment in Patients With Hepatitis B Recent recommendations and their impact on the management of patients with hepatitis B, including immune-tolerant hepatitis B, immune-active hepatitis B, and inactive chronic hepatitis, are reviewed.
  • Understanding Acute-on-Chronic Liver Failure A condition with a variety of classifications, associated complications, and manifestations, acute-on-chronic liver failure requires early identification to lessen the risk for patient mortality.
  • Screening for Hepatocellular Carcinoma Learn the risk factors for hepatocellular carcinoma, and who to screen, how often to screen, and what tools should be used.
  • HCV Treatment: What Can I Do Now? What's Coming Next? As direct-acting antivirals continue to show success in HCV, the possibility for treatment expands to an even greater number of patient groups.
  • The Challenges Surrounding Primary Sclerosing Cholangitis In navigating issues such as differential diagnoses and a confounding lack of clear treatment options, clinicians are best suited by following the most recent guidelines in this area.
  • Finding the Patient With Primary Biliary Cirrhosis If you don't consider it, you might miss the diagnosis of this slowly progressive autoimmune disorder.
  • Drug-Induced Liver Injury: What You Need to Know Drug-induced liver injury is increasing and is the primary cause of need for liver transplantation. Learn how to assess for and diagnose drug-induced hepatotoxicity.